am
1:37
All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily

What To Expect From Johnson & Johnson’s Q4?

(January 19 00:00) Forbes.com
The company will likely see a steady rise in revenue led by continued market share gains for its drugs - Darzalex, Stelara, Erleada, and Tremfya.
You can find the original article here
Who we are Terms of use News Sites Submit Site